Medical Grand Rounds

Jeffrey Samet, MD, MPHJeffrey Samet, MD, MPH, served as the UAB Department of Medicine's Tinsley Harrison Visiting Professor on September 6-7, 2016. Dr. Samet is a world-renowned researcher and educator in the care and public health response to addiction and past president of the American Board of Addiction Medicine. 

The Chief of the Section of General Internal Medicine at Boston Medical Center and Founding Director of the Clinical Addictions Research and Education Unit at Boston University School of Medicine will presented two lectures on the topic of opiate addition.

Baskin Monica PhDMonica Baskin, PhD, Professor of Medicine in the Division of Preventive Medicine, will serve as the first Vice Chair for Culture and Diversity in the Department of Medicine. As Vice Chair, Monica will lead our efforts to develop a culture of respect and inclusion, working with each Division to capitalize on the diverse backgrounds of our faculty, staff, and learners.

Monica joined the Department in 2009 after receiving a bachelor of arts from Emory University, a master’s and doctorate in Counseling Psychology from Georgia State University, and serving on the faculties of the Schools of Public Health

Turnipseed Elizabeth MDElizabeth Turnipseed, MD, Assistant Professor of Medicine, has been appointed Vice Chair for Clinical Affairs in the UAB Department of Medicine. A former resident and Chief Medical Resident at UAB and faculty physician in the Hospitalist Program, Elizabeth joined the Division of General Internal Medicine and the Department three years ago as Assistant Vice Chair for Clinical Affairs, soon thereafter rising to Co-Vice Chair.  

Landefeld Seth MDUniversity of Alabama at Birmingham professor and chair of the UAB Department of Medicine C. Seth Landefeld, M.D., has been appointed to the U.S. Preventive Services Task Force. The Task Force is an independent, volunteer panel comprised of experts from many health-related fields, including internal medicine, pediatrics, behavioral health, obstetrics/gynecology, and nursing. Each is appointed by the director of the Agency for Healthcare Research and Quality, a part of the U.S. Department of Health and Human Services.

There has been a dramatic change in sickle cell disease treatment outcomes in our lifetimes. In the early 1970s, being diagnosed with this genetic disorder was more like receiving a death sentence. Children were not expected to live past the age of 16. Today, sickle cell patients can live well into their 40s. Despite these terrific advances in treatment, nearly 3,000 Alabamians still struggle to manage sickle cell disease today.

Michael Bell, Selwyn Vickers, MD, Sharon Lewis, and Ravi Bhatia, MDSickle Cell Foundation Board President Michael Bell with UAB School of Medicine Dean Selwyn Vickers, MD, Foundation Executive Director Sharon Lewis, and Hematology/Oncology Division Director Ravi Bhatia, MD